Using a Bayesian approach with reverse philosophy to design clinical trials in rare diseases

Ítems similars

• The use of Bayesian design in two trials in rare cancers
  per: Dutton, Peter, et al.
  Publicat: (2015)
• Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia
  per: Yap, Christina, et al.
  Publicat: (2011)
• Dose transition pathways: a design, analysis and operational tool for dose-finding trials using model-based designs
  per: Yap, Christina, et al.
  Publicat: (2015)
• Trials in rare diseases: the need to think differently
  per: Billingham, Lucinda, et al.
  Publicat: (2011)
• Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges
  per: Yap, Christina, et al.
  Publicat: (2013)